CN103735883A - Anti-primary hypertension medicament - Google Patents
Anti-primary hypertension medicament Download PDFInfo
- Publication number
- CN103735883A CN103735883A CN201410036204.0A CN201410036204A CN103735883A CN 103735883 A CN103735883 A CN 103735883A CN 201410036204 A CN201410036204 A CN 201410036204A CN 103735883 A CN103735883 A CN 103735883A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- medicine
- medicament
- hypertension
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the field of biological medicines, and relates to an anti-primary hypertension medicament. The medicament is prepared from notoginseng, epimedium, salvia miltiorrhiza, gastrodia elata, American ginseng and cortex phellodendri serving as main raw materials, and has a better antihypertensive effect.
Description
Technical field
The invention belongs to biomedicine field, relate to a kind of medicine of antigen Essential hypertension.
Background technology
Hypertension (hypertensive disease) is a kind of chronic disease take the lasting rising of arteriotony as main manifestations, often cause the pathological changes of the vitals such as the heart, brain, kidney and occur corresponding consequence, hypertension belongs to " headache ", " dizzy " category of the traditional Chinese medical science.The blood pressure standard that World Health Organization's suggestion is used is: normal adult systolic pressure should be less than or equal to 140mmHg, and diastolic pressure is less than or equal to 90mmHg; Systolic pressure is between 141-159mmHg, and diastolic pressure, between 91-94mmHg, is borderline hypertension.
Doctor trained in Western medicine is emphasized individualized treatment, and the traditional Chinese medical science is focused on determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs.Western medicine hypertension, adopts index treatment, is often too concerned about an index of hypertension therapeutic, i.e. blood pressure values index, under treatment-resistant, seems blood pressure index normal, in fact easily repeatedly.From theory of Chinese medical science, Chinese medicine due to row neutralization, in just, Zhong Hangzhi road, in hypertensive control, conditioning viscera function, prevents and treats complication, has its relatively unique " treating both the principal and secondary aspects of a disease " advantage.Treatment by Chinese herbs is mainly environment in the blood of adjusting disorder in body; repair impaired blood vessel wall; improve oxygen content; recover injured cranial nerve cell, adjust the vital organs of the human body, qi blood balance; dredging the meridian; reach equilibrium between yin and yang, there is integrally-regulated and feature individualized treatment, at aspects such as improving hypertension clinical symptoms, protection target organ, there is unique advantage.Common blood pressure lowering Chinese patent medicine has An ' gong blood pressure-reducing ball, Chinese hawthorn blood-pressure-reducing capsule, compound recipe antelope angle hypertension pill, chiang ya wan, chrysanthemum publicly price-reduction tabletting, Bezoar pill for lowering blood pressure etc.; Common Chinese hypotensor has Ramulus Uncariae Cum Uncis, Folium Apocyni Veneti, Radix Puerariae, the Radix Astragali etc.
Summary of the invention
The object of the present invention is to provide a kind of medicine of antigen Essential hypertension.
Specifically, the present invention is comprised of the component of following weight proportion: Radix Notoginseng 20-40 part, Herba Epimedii 10-20 part, Radix Salviae Miltiorrhizae 15-25 part, Rhizoma Gastrodiae 5-10 part, Radix Panacis Quinquefolii 5-15 part, Cortex Phellodendri 5-10 part.
The present invention can effectively reduce blood pressure, and improves the symptoms such as hyperpietic's dizziness, headache, cardiopalmus, blurred vision.
The present invention can also contain pharmaceutics acceptable carrier, comprise excipient and adjuvant, described excipient and adjuvant have starch, microcrystalline Cellulose, inorganic salts, hydroxypropyl emthylcellulose, ethyl cellulose, polyacrylic resin class, polycarboxy ethene, solubility/insoluble the salt of alginic acid, octadecanol, stearic acid, sucrose, dextrin, lactose, Icing Sugar, glucose, sodium chloride, cysteine, the compositions of one or more materials of citric acid and sodium sulfite etc., coating material comprises Lac, cellulose acetate, CAP, ethyl cellulose, hydroxypropyl emthylcellulose, hydroxypropyl cellulose, crylic acid resin, polyvinyl acetate phthalic acid ester, Hydroxypropyl Methyl Cellulose Phthalate, succinic acid acetic acid hydroxypropyl methylcellulose, hydroxypropylmethylcellulose acetate methylcellulose phthalate ester, glyceryl monostearate, and the various medicaments adjuvant such as plasticizer and porogen.
The present invention can be the dosage form on any pharmaceutics, and preferred oral preparation, as capsule, tablet or granule etc.
The specific embodiment
Embodiment 1. main raw materials in proportion
30 parts of Radix Notoginseng, 20 parts of Herba Epimedii, 15 parts of Radix Salviae Miltiorrhizaes, 10 parts, Rhizoma Gastrodiae, 12 parts of Radix Panacis Quinquefoliis, 7 parts of Cortex Phellodendris.
Embodiment 2. main raw materials in proportion
20 parts of Radix Notoginseng, 15 parts of Herba Epimedii, 20 parts of Radix Salviae Miltiorrhizaes, 8 parts, Rhizoma Gastrodiae, 5 parts of Radix Panacis Quinquefoliis, 10 parts of Cortex Phellodendris.
Embodiment 3. main raw materials in proportion
40 parts of Radix Notoginseng, 10 parts of Herba Epimedii, 25 parts of Radix Salviae Miltiorrhizaes, 5 parts, Rhizoma Gastrodiae, 15 parts of Radix Panacis Quinquefoliis, 5 parts of Cortex Phellodendris.
Embodiment 4. observation of curative effect
Wu, 62 years old, suffer from essential hypertension for many years, former powder fill becomes capsule, and each 1 gram, every day 2-3 time, to take continuously after 1 month, blood pressure returns to normal value, and the hypertension symptoms such as dizziness, headache, cardiopalmus, blurred vision obviously improve.
Claims (2)
1. a medicine for antigen Essential hypertension, is characterized in that being comprised of the component of following weight proportion:
Radix Notoginseng 20-40 part Herba Epimedii 10-20 part Radix Salviae Miltiorrhizae 15-25 part
Rhizoma Gastrodiae 5-10 part Radix Panacis Quinquefolii 5-15 part Cortex Phellodendri 5-10 part
2. the medicine of a kind of antigen Essential hypertension according to claim 1, is characterized in that dosage form is the peroral dosage forms such as capsule, tablet or granule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410036204.0A CN103735883A (en) | 2014-01-26 | 2014-01-26 | Anti-primary hypertension medicament |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410036204.0A CN103735883A (en) | 2014-01-26 | 2014-01-26 | Anti-primary hypertension medicament |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103735883A true CN103735883A (en) | 2014-04-23 |
Family
ID=50492999
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410036204.0A Pending CN103735883A (en) | 2014-01-26 | 2014-01-26 | Anti-primary hypertension medicament |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103735883A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102302684A (en) * | 2011-09-23 | 2012-01-04 | 唐红芳 | Radix notoginseng tablets for promoting blood circulation |
-
2014
- 2014-01-26 CN CN201410036204.0A patent/CN103735883A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102302684A (en) * | 2011-09-23 | 2012-01-04 | 唐红芳 | Radix notoginseng tablets for promoting blood circulation |
Non-Patent Citations (1)
| Title |
|---|
| 黄晓瑾等: "具有抗高血压作用中药的规律探讨", 《上海中医药杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103735622A (en) | Primary hypertension resistance medicine | |
| CN103735881A (en) | Compound preparation | |
| CN103623248A (en) | Traditional Chinese medicinal composition for reducing blood pressure | |
| CN101612223A (en) | Traditional Chinese medicine for benefiting heart and strengthening brain | |
| CN101584795A (en) | Traditional Chinese medicine for treating breast obstruction and breast distending pain | |
| CN102657828B (en) | Pharmaceutical composition for treating chronic heart failure | |
| CN102488838B (en) | Traditional Chinese medicine composition used for treating viral myocarditis | |
| CN103735883A (en) | Anti-primary hypertension medicament | |
| CN103735882A (en) | Preparation containing panax notoginseng | |
| CN103751270A (en) | Compound antihypertensive preparation | |
| CN102920815A (en) | Application of active parts of gambir plant total alkaloids | |
| CN102657744B (en) | Medicament for treating mastitis | |
| CN1259090C (en) | Oral liquid for treating common cold and coughing | |
| CN104645207A (en) | Traditional Chinese medicine composition for treating angina | |
| CN103211904A (en) | Medicament for treating hypotension | |
| CN1168473C (en) | Chinese medicine prepn for treating arterioscleriosis | |
| CN103919845A (en) | Pharmaceutical composition for improving anoxia endurance and preparation method and application thereof | |
| CN102406843A (en) | Chinese medicinal composition for treating coronary disease | |
| CN103393912A (en) | Traditional Chinese medicine used for treating coronary heart disease | |
| CN103301368A (en) | Medicament for treating hyperactivity | |
| CN102772665B (en) | Traditional Chinese medicine preparation for treating yin deficiency and internal heat type vital myocarditis and preparation method thereof | |
| CN102423359A (en) | Drug for restoring renal functions and curing various nephrosis such as nephritis, uremia and the like | |
| CN101066391A (en) | Medicine composition for treating hypertension | |
| CN102920725A (en) | New application of traditional Chinese medicine extract | |
| CN108210721A (en) | A kind of Chinese medicine composition for being used to treat liver-kidney yin deficiency Hiccough and deaf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140423 |